IRCT20200105046010N53招募中未知
In- Vivo Bioequivalence study of Linalidomide capsule 25 mg (Actero Pharma., Iran) with brand drug (REVLIMID® 25 mg, Celgene, Bristol-Myers Squibb,UK) in Iranian healthy volunteers.
Actero middle east Pharm. Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-55 years old
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
不适用
enalidomide cap. 25mg Sobhan Oncology (LENASOB® 25mg), In-Vivo Bioequivalence in iranian healthy volunteer.In this study, the disease is not examined. Subject bioequivalence test and reference tablets Teriflunomide studied..IRCT20200105046010N26SOBHAN ONCOLOGY Pharmaceutical24
尚未招募
不适用
enalidomide tablet 25mg ABIDI (MYLODEQ® 25mg), In-Vivo Bioequivalence in iranian healthy volunteer, In-Vivo Bioequivalence in iranian healthy volunteerIn this study the bioequivalence of test and brand of Lenalidomide tablet will evaluated..IRCT20200105046010N6Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Indapamide 1.5 mg tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N65Tabriz University of Medical Sciences24
尚未招募
不适用
igagliptin tablets 5mg ABIDI Pharmaceuticals (TRAJENTA® 5mg Tab) , In- Vivo Bioequivalence in Iranian healthy volunteers.IRCT20200105046010N8Tabriz University of Medical Sciences24
招募中
不适用
In-vivo Bioequivalence study of Tadalafil tablet with brand drugs (CIALIS Lilly USA)IRCT20200105046010N39Mofid Pharmaceutical Co.24